Advertisement

Topics

Kiadis enters €15mm debt facility with Kreos; gets €10mm up front

15:40 EDT 18 Aug 2017 | Elsevier Business Intelligence

Kiadis Pharma Netherlands BV (cell-based immunotherapies) entered into a €15mm ($17.6mm) debt facility with Kreos Capital, ...

Original Article: Kiadis enters €15mm debt facility with Kreos; gets €10mm up front

NEXT ARTICLE

More From BioPortfolio on "Kiadis enters €15mm debt facility with Kreos; gets €10mm up front"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...